{"id":432855,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2014-12-05] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:02:03.065000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-6.html?wbdisable=true","snippet":"Notice - Prescription Drug List (PDL): Multiple additions December 5, 2014 Our file number: 14-115019-499 The purpose of this Notice of Amendment is to notify the addition of Agalsidase Beta, Apremilast, Azelastine, Basedoxifene, Ibrutinib and Ledispasvir to both the Human and…","rawSnapshotUrl":"/api/snapshots/raw/432855","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090203/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-6.html?wbdisable=true#ha_snapshot=432855","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}